CGA
CVS icon

Crescent Grove Advisors’s CVS Health CVS Stock Holding History

Crescent Grove Advisors’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$380K Sell
3,676
-1,530
-29% -$137K 0.03% 214
2026
Q1 		$374K Hold
5,206
– – 0.04% 206
2025
Q4 		$413K Sell
5,206
-1,265
-20% -$99.7K 0.04% 198
2025
Q3 		$488K Buy
6,471
+165
+3% +$11.3K 0.05% 173
2025
Q2 		$435K Buy
6,306
+30
+0.5% +$1.97K 0.04% 173
2025
Q1 		$425K Buy
6,276
+315
+5% +$18.9K 0.04% 169
2024
Q4 		$268K Sell
5,961
-499
-8% -$28K 0.03% 229
2024
Q3 		$406K Buy
6,460
+401
+7% +$23.4K 0.04% 185
2024
Q2 		$358K Buy
6,059
+1,800
+42% +$113K 0.04% 193
2024
Q1 		$340K Sell
4,259
-634
-13% -$48.4K 0.04% 221
2023
Q4 		$386K Buy
4,893
+1,136
+30% +$80.9K 0.04% 202
2023
Q3 		$262K Buy
3,757
+481
+15% +$34.1K 0.03% 236
2023
Q2 		$226K Buy
+3,276
New +$233K 0.02% 266
2023
Q1 		– Sell
-3,308
Closed -$308K – 285
2022
Q4 		$308K Buy
3,308
+1,210
+58% +$117K 0.03% 227
2022
Q3 		$200K Buy
+2,098
New +$208K 0.02% 246
2022
Q2 		– Sell
-3,583
Closed -$363K – 271
2022
Q1 		$363K Sell
3,583
-563
-14% -$59.1K 0.04% 204
2021
Q4 		$428K Sell
4,146
-3,789
-48% -$350K 0.04% 181
2021
Q3 		$673K Buy
7,935
+3,587
+82% +$300K 0.07% 131
2021
Q2 		$363K Sell
4,348
-503
-10% -$41.2K 0.04% 173
2021
Q1 		$365K Buy
+4,851
New +$353K 0.04% 149

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Crescent Grove Advisors's CVS Position: Q2 2026 in Review

Crescent Grove Advisors reduced its CVS Health (CVS) stake by 29% in Q2 2026, selling an estimated $137K and leaving 3,676 shares worth $380K. The position accounts for 0.03% of the portfolio, ranked #214.

Crescent Grove Advisors first reported a position in CVS in Q1 2021 and has held it in 20 quarters since. The position peaked at $673K in Q3 2021. 2,074 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Crescent Grove Advisors held 3,676 shares of CVS Health worth $380K as of Q2 2026.
  • Crescent Grove Advisors sold 1,530 CVS Health shares in Q2 2026, an estimated $137K.
  • CVS Health made up 0.03% of Crescent Grove Advisors's portfolio in Q2 2026, its #214 holding.
  • Crescent Grove Advisors first reported a position in CVS Health in Q1 2021 and has held it in 20 quarters since.
  • Crescent Grove Advisors's CVS Health position peaked at $673K in Q3 2021.
  • 2,074 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Crescent Grove Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.